Why the study?
Does type 2 diabetes impact exercise capacity in asymptomatic, normotensive patients without coronary artery disease?
Case-Control (n=63)
Does type 2 diabetes impact exercise capacity in asymptomatic, normotensive patients without coronary artery disease?
Type 2 diabetes is associated with significantly reduced exercise capacity in normotensive patients without coronary artery disease, independent of diastolic dysfunction.
Answers are grounded in this paper and cite their sources.
Should not yet change exercise assessment in asymptomatic patients; leaves open mechanisms and prognostic value of reduced VO2 max.
OBJECTIVE: The aim of this study was to determine the impact of diabetes and diastolic dysfunction on exercise capacity in asymptomatic, normotensive patients with type 2 diabetes without coronary artery disease. METHODS: A total of 43 type 2 diabetes patients (age: 50 ± 5 years) and 20 healthy controls (age: 48 ± 4 years) were enrolled. Diastolic function was investigated by conventional pulsed-wave (PW) Doppler and tissue Doppler imaging (TDI). Exercise capacity was evaluated with cardiopulmonary exercise testing (CPET). RESULTS: In patients with type 2 diabetes, increase in resting heart rate (HR-rest) (p = 0.013), decrease in maximum heart rate during exercise (HR-max) (p < 0.001) and exercise time (p < 0.001) compared with controls were significant. Patients had significantly increased minute ventilation volume (VE)/maximum carbon dioxide discharge (VCO2) ratio (p < 0.001), decreased maximum oxygen consumption (VO2-max) (p < 0.001), oxygen consumption at anaerobic threshold (VO2-an) (p < 0.001) and maximum carbon dioxide discharge (VCO2) (p < 0.001) compared to controls indicating significantly reduced exercise capacity. HbA1c was inversely correlated with VO2-max (r = -0.456, p < 0.01) independent of the absence or presence of mild diastolic dysfunction. CONCLUSION: Exercise capacity was found to be significantly decreased in normotensive patients with type 2 diabetes without coronary artery disease, and this decrease was independent of diastolic dysfunction.
No takes yet. Share an insight, caveat, or question.
Gürdal et al. (2015) conducted a case-control in Type 2 diabetes (n=63). Type 2 diabetes vs. Healthy controls was evaluated on Maximum oxygen consumption (VO2-max) (p=<0.001).
Synapse has enriched 10 related papers. Consider them for comparative context: